EHC, US29261A1007

Encompass Health stock gained 0.62 percent before Q3 results

Published on 10/05/2026 at 15:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Encompass Health stock was last at USD 119.80 on October 2, 2026, while the company set its third-quarter reporting date. Q2 revenue reached USD 1.60 billion and consensus sees USD 148.17.

EHC, US29261A1007, Illustration mit AI erstellt.
EHC, US29261A1007, Illustration mit AI erstellt.

Encompass Health stock (ISIN US29261A1007) was last at USD 119.80 on the NYSE on October 2, 2026, up 0.62 percent from the previous session. The company will report third-quarter 2026 results after the market close on October 28, giving the next earnings event a firm date.

Third-quarter date is set

According to StockTitan on October 1, 2026, Encompass Health will publish results for the quarter ended September 30, 2026, after the market closes on October 28. Management will discuss the figures during a conference call at 10:00 a.m. ET on October 29, 2026.

The scheduled report follows a strong second quarter. Simply Wall St reported that second-quarter 2026 revenue reached USD 1.60 billion, up 9.6 percent from the second quarter of 2025, while net income rose 8.3 percent to USD 154.5 million. Adjusted earnings per share came in at USD 1.56, compared with USD 1.42 a year earlier.

Consensus points above USD 148

The analyst view also gives the October report a clear valuation checkpoint. According to Investing.com on September 30, 2026, the consensus rating was Strong Buy from 12 analysts, with an average 12-month price target of USD 148.17. The published high target was USD 155.00 and the low target was USD 140.00.

That average target lies 23.7 percent above the October 2 price of USD 119.80. The comparison puts the upcoming quarterly report in practical terms: revenue growth and earnings quality must support the valuation gap, while hospital expansion adds capacity over a longer timetable.

Stock remains below yearly high

Encompass Health was last at USD 119.80 on October 2, 2026, against a 52-week range of USD 92.77 to USD 127.99. Its market capitalization was USD 11.9 billion and trading volume was 1,095,403 shares on that date.

Encompass Health stock details

  • Company: Encompass Health Corporation
  • ISIN: US29261A1007
  • Ticker: EHC
  • Trading venue: NYSE
  • Price (as of October 2, 2026): USD 119.80
  • Market capitalization: USD 11.9 billion (as of October 2, 2026)
  • 52-week range: USD 92.77-127.99 (as of October 2, 2026)
  • Sector / Industry: Health Care / Health Care Providers and Services

Upcoming dates for Encompass Health stock

  • October 28, 2026: Third-quarter 2026 results after the market close
  • October 29, 2026: Investor conference call at 10:00 a.m. ET

More news and analyses on Encompass Health stock

Disclaimer...

en | US29261A1007 | EHC | boerse | 70233500 | bgmi